CDC25C and neoplasm: Distinct from CDC25A and CDC25B, the methylation level of CDC25C decreased in most tumor tissues, including KIRP, LUSC, PRAD, UCEC, LIHC, BLCA, LUAD, and pheochromocytoma and paraganglioma (PCPG).